Why Jim Cramer Sees ‘Another Bad Quarter Ahead’ For Ford, And What Will Turn Things Around
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Vista Outdoor Inc (NYSE: VSTO) can be "bought here. I would not push it, though."
Why Tesla Rival Polestar’s Stock Spiked Over 20% Today
Polestar Automotive Holding UK Ltd (NASDAQ:PSNY) announced an important production milestone for its Polestar 2 electric vehicles on…
AbbVie Finalizes To Pay Around $2.4B In Settlement Against US Opioid Lawsuits
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) and AbbVie Inc (NYSE:ABBV) have finalized the settlement’s terms worth over $6.6 billion to resolve several…
George Soros Bought 2 New Dividend Paying Stocks, Upped His Stake In This Media Giant By Over 300%
Soros Fund Management is structured as a family office, formerly a hedge fund, and is reported to be one of the most profitable hedge funds in the industry.
Retailers Are Sitting On Record High Inventories: What That Means For Black Friday Shoppers
Dell Technologies Inc (NYSE: DELL) has too many computers on hand, while Nike Inc. (NYSE: NKE) is flooded with summer fashion.
Is The Mall Making A Comeback? Abercrombie, Best Buy And American Eagle Beat Expectations
Staples of American retail Abercrombie & Fitch Co. (NYSE: ANF), Best Buy (NYSE: BBY) and American Eagle Outfitters Inc.
Meta Platforms Denies Zuckerberg Plans To Resign: What You Need To Know
Meta Platforms Inc (NASDAQ: META) denied a report Tuesday that founder and CEO Mark Zuckerberg is set to resign as early as next year amid the company losing billions on its Metaverse investments.
Cathie Wood Increases Stake In 4 Stocks By Over 1,000% – Plus 4 New Holdings For Ark
Cathie Wood’s ARK Innovation ETF (ARCA: ARKK) is down roughly 63% year-to-date, compared to the NASDAQ which is down at least 29% year-to-date and the S&P 500 down over 16% year-to-date.
Big Tech Layoffs Are Big News, But Not For The Overall Labor Market — Here’s What New Data Is Showing
Tech companies have recently been announcing massive and unprecedented waves of layoffs — sometimes by the tens of thousands. Here's the latest:
Merck’s Keytruda Phase 3 Trial Meets Primary Endpoint In Gastric Cancer Patients
Merck & Co Inc (NYSE:MRK) has announced topline results from the pivotal Phase 3 KEYNOTE-859 trial of its flagship anti-PD-1 therapy,…